How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,359 results for

Skin Discoloration

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Use of Munsell Color Charts to Measure Skin Tone Objectively in Nursing Home Residents at Risk for Pressure Ulcer Development Full Text available with Trip Pro

Use of Munsell Color Charts to Measure Skin Tone Objectively in Nursing Home Residents at Risk for Pressure Ulcer Development To assess the feasibility of classifying skin tone using Munsell color chart values and to compare Munsell-based skin tone categories to ethnicity/race to predict pressure ulcer risk.Pressure ulcer classification uses level of visible tissue damage, including skin discoloration over bony prominences. Prevention begins with early detection of damage. Skin discoloration (...) in those with dark skin tones can be difficult to observe, hindering early detection.Observational cohort of 417 nursing home residents from 19 nursing homes collected between 2009-2014, with weekly skin assessments for up to 16 weeks.Assessment included forearm and buttocks skin tone based on Munsell values (Dark, Medium, Light) at three time points, ethnicity/race medical record documentation, and weekly skin assessment on trunk and heels.Inter-rater reliability was high for forearm and buttock

2016 Journal of advanced nursing

42. Discoloration of nail beds and skin from minocycline Full Text available with Trip Pro

Discoloration of nail beds and skin from minocycline 21098068 2011 04 05 2018 11 13 1488-2329 183 2 2011 Feb 08 CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne CMAJ Discoloration of nail beds and skin from minocycline. 224 10.1503/cmaj.091498 Tavares John J Faculty of Medicine, University of Ottawa, Ottawa, Ont., Canada. Leung Wilson W S WW eng Case Reports Journal Article 2010 11 22 Canada CMAJ 9711805 0820-3946 0 Anti-Bacterial Agents FYY3R43WGO (...) Minocycline AIM IM Anti-Bacterial Agents adverse effects Humans Male Middle Aged Minocycline adverse effects Nail Diseases chemically induced Pigmentation Disorders chemically induced Rosacea drug therapy Skin Pigmentation drug effects 2010 11 25 6 0 2010 11 26 6 0 2011 4 6 6 0 ppublish 21098068 cmaj.091498 10.1503/cmaj.091498 PMC3033929 Drug Saf. 1998 Jun;18(6):431-40 9638388

2011 CMAJ : Canadian Medical Association Journal

43. A double-blind, placebo-controlled randomized trial of Serratulae quinquefoliae folium, a new source of β-arbutin, in selected skin hyperpigmentations. (Abstract)

on the discolored side for 8 weeks.The experimental data showed that the cream with the extract causes decreased level of melanin in the skin pigmentation spot. Clinical effect in the form of lightening and evening skin tone on the discolored side was observed in 75.86% of the female patients with melasma and 56.00 % of the female patients with lentigo solaris.The cream with the aqueous extract from leaf of five-leaf serratula proved to be an effective and safe preparation for lightening skin discolorations (...) A double-blind, placebo-controlled randomized trial of Serratulae quinquefoliae folium, a new source of β-arbutin, in selected skin hyperpigmentations. Arbutin is one of the most effective lightening substances. Serratula quinquefolia is a new source of its β-anomer. The HPLC method showed that the solid content of this compound in the dried plant raw material accounts for 6.86%. The leaves of Serratula quinquefolia do not contain hydroquinone.To assess the efficacy of the aqueous extract from

2015 Journal of cosmetic dermatology Controlled trial quality: uncertain

44. Skin Cancer, Melanoma

Skin Cancer, Melanoma Melanoma Treatment (PDQ®)—Health Professional Version - National Cancer Institute Menu Search Search Search General Information About Melanoma Melanoma is a malignant tumor of melanocytes, which are the cells that make the pigment melanin and are derived from the neural crest. Although most melanomas arise in the skin, they may also arise from mucosal surfaces or at other sites to which neural crest cells migrate, including the uveal tract. Uveal melanomas differ (...) significantly from cutaneous melanoma in incidence, prognostic factors, molecular characteristics, and treatment. (Refer to the PDQ summary on for more information.) Incidence and Mortality Estimated new cases and deaths from melanoma in the United States in 2019:[ ] New cases: 96,480. Deaths: 7,230. Skin cancer is the most common malignancy diagnosed in the United States, with 5.4 million cancers diagnosed among 3.3 million people in 2012.[ ] Invasive melanoma represents about 1% of skin cancers

2012 PDQ - NCI's Comprehensive Cancer Database

45. Reducing Side-effects of Autologous Skin Tissue Harvesting

donor site wounds, causing numerous complications including pain, infection, blistering, discoloration, and scarring. Based on previous research, many of these adverse effects can be improved, or even eliminated, by harvesting skin tissue in very small biopsies. These "micro-biopsies" are less than the size of a sewing pin. Then, they are put back together into a skin graft. This concept is based on clinical observations from fractional photothermolysis laser therapy, an FDA approved laser that has (...) Reducing Side-effects of Autologous Skin Tissue Harvesting Reducing Side-effects of Autologous Skin Tissue Harvesting - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Reducing Side-effects of Autologous Skin

2014 Clinical Trials

46. A survey of self-reported skin disease in the elderly African-American population. (Abstract)

/pruritus (40.6%), moles (27.7%), hair loss (25.7%), skin discoloration (20.8%), and wrinkles (15.8%). Overall, 40.6% of participants reported concern about skin cancer, and 75.2% reported examining their skin regularly. However, 34.7% did not believe that people with darker skin types should be concerned about skin cancer.This study provides an important overview of the most common self-reported skin conditions in elderly African-Americans. Substantial age-related differences in the frequencies of skin (...) A survey of self-reported skin disease in the elderly African-American population. In the USA, the geriatric population, almost 12% of which will be comprised of African-Americans, is expected to exceed 88 million by 2050. Data on dermatologic conditions in elderly African-Americans are deficient.This study aimed to identify prevalences of self-reported skin disease and skin-related concerns in elderly African-Americans, and to assess participants' perceptions of skin disease and awareness

2014 International Journal of Dermatology

47. The Role of Sentinel Node Biopsy in Skin Cancer (Treatment)

node biopsy. Long-term postoperative sequelae may include persistent blue discoloration of the skin at the injection site (for >30 d in < 10% of patients), lymphatic fistulae, lymphocele, lymphedema (generally < 2% and 0.66% in 1 large trial for sentinel node biopsy alone), and neurologic complications, including transient or persistent neurapraxia, cutaneous anesthesia, paresthesias, and neuropathy. Sentinel lymph node biopsy does not increase the risk of in-transit metastases. The risk (...) The Role of Sentinel Node Biopsy in Skin Cancer (Treatment) The Role of Sentinel Node Biopsy in Skin Cancer Treatment & Management: Surgical Therapy, Preoperative Details, Intraoperative Details Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache

2014 eMedicine.com

48. Facial Analysis for Skin Resurfacing

, especially with regard to pigmentation and scarring. [ ] Previous Next: Classification Of Rhytidosis Glogau developed the following traditional rhytide/photoaging classification scheme that is used most often in current practice: Mild (age 28-35 y) - Little wrinkles, no keratosis, requires little or no makeup for coverage Moderate (age 35-50 y) - Early wrinkling, sallow complexion with early actinic keratosis, requires little makeup Advanced (age 50-60 y) - Persistent wrinkling, discoloration of the skin (...) and visible wrinkle; greater than 2 mm but less than 3 mm wrinkle depth 3- Deep wrinkle; deep and furrow wrinkle; greater than 3 mm wrinkle depth Fitzpatrick also correlated these three classes with the following scoring system and degree of elastosis: Class I (score 1-3) - Mild elastosis Class II (score 4-6) - Moderate elastosis Class III (score 7-9) - Severe elastosis Mild elastosis is defined as fine textural changes with minimal skin lines. Moderate denotes a yellow discoloration of individual papules

2014 eMedicine Surgery

49. Skin, Congenital Hairy Nevi

Skin, Congenital Hairy Nevi Congenital Hairy Nevi: Overview, Clinical Presentation, Differential Diagnosis Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTI5NTAzMy1vdmVydmlldw== processing > Congenital Hairy Nevi (...) is addressed at age 6 months. [ , , ] Procedures used in surgical treatment include serial excision [ ] and reconstruction with skin grafting, tissue expansion, local rotation flaps, and free tissue transfer. [ ] Adjunctive treatment options include , , and . For more information, visit Medscape’s . Surgical excision remains the mainstay of treatment, since other adjunctive treatment options do not fully eradicate the nevus cells. Cultured epidermal autographs have been used successfully in select cases

2014 eMedicine Surgery

50. Skin Resurfacing: Dermabrasion

Formation and Photoaging Skin Type Age (y) Clinical Findings I (mild) 20-30 Early photoaging, fine wrinkling II (moderate) 30-40 Early to moderate photoaging, present with motion, no keratoses III (advanced) 50 and over Advanced photoaging, wrinkles with rest, visible keratoses, noticeable discolorations IV (severe) 60 and over Severe photoaging, wrinkles throughout, dynamic and gravitational wrinkling, actinic keratoses Contributor Information and Disclosures Author Gaurav Bharti, MD, FACS Plastic (...) Skin Resurfacing: Dermabrasion Dermabrasion: Practice Essentials, Background, Anatomy Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTI5NzA2OS1vdmVydmlldw== processing > Dermabrasion Updated: May 18, 2018 Author

2014 eMedicine Surgery

51. Skin Resurfacing, Laser: Carbon Dioxide

, benign skin growths such as seborrheic keratosis, solar elastosis, senile comedones, telangiectasia, yellowish discoloration, mottled hyperpigmentation, and skin laxity. In general, patients with early photodamage do not require carbon dioxide laser resurfacing. The ideal patient has mild-to-moderate photoaging. History of : Start suppressive therapy with oral antiviral medications 1-2 days before procedure and continue until complete reepithelialization takes place. History of frequent : Administer (...) Skin Resurfacing, Laser: Carbon Dioxide Carbon Dioxide Laser Skin Resurfacing: Background, Pathophysiology, Presentation Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTI5NjgwNi1vdmVydmlldw== processing > Carbon

2014 eMedicine Surgery

52. Skin Resurfacing, Dermabrasion

Formation and Photoaging Skin Type Age (y) Clinical Findings I (mild) 20-30 Early photoaging, fine wrinkling II (moderate) 30-40 Early to moderate photoaging, present with motion, no keratoses III (advanced) 50 and over Advanced photoaging, wrinkles with rest, visible keratoses, noticeable discolorations IV (severe) 60 and over Severe photoaging, wrinkles throughout, dynamic and gravitational wrinkling, actinic keratoses Contributor Information and Disclosures Author Gaurav Bharti, MD, FACS Plastic (...) Skin Resurfacing, Dermabrasion Dermabrasion: Practice Essentials, Background, Anatomy Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTI5NzA2OS1vdmVydmlldw== processing > Dermabrasion Updated: May 18, 2018 Author

2014 eMedicine Surgery

53. Skin Resurfacing, Laser: Erbium YAG

complexion with early actinic keratosis, require little makeup Usually aged 35-50 years Type III Persistent wrinkling, discoloration of the skin with telangiectasias and actinic keratosis, always wear makeup Usually aged 50-60 years Type IV Severe wrinkling, photoaging, gravitational and dynamic forces affecting skin, actinic keratosis, wear makeup with poor coverage Usually aged 65-70 years Patients categorized in Fitzpatrick and Glogau types I and II obtain better results than those in higher types (...) Skin Resurfacing, Laser: Erbium YAG Erbium YAG Laser Skin Resurfacing: Background, Problem, Epidemiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTI5NjkwOC1vdmVydmlldw== processing > Erbium YAG Laser Skin

2014 eMedicine Surgery

54. Skin Resurfacing: Chemical Peels

medical and drug history is very important. Medical conditions such as cardiac, hepatic, or renal disease may influence treatment decisions and the choice of peeling agents. Exogenous estrogens, oral contraceptives, and other medications may be photosensitizing and predispose patients to pigmentation complications after chemical peeling and worsening the skin discoloration that the chemical peel was intended to eradicate. Patients taking blood thinners, such as warfarin, should avoid deep peels (...) Skin Resurfacing: Chemical Peels Chemical Peels: Background, Indications, Contraindications Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTgyOTEyMC1vdmVydmlldw== processing > Chemical Peels Updated: Jul 26, 2017

2014 eMedicine Surgery

55. Skin Resurfacing, Chemical Peels

medical and drug history is very important. Medical conditions such as cardiac, hepatic, or renal disease may influence treatment decisions and the choice of peeling agents. Exogenous estrogens, oral contraceptives, and other medications may be photosensitizing and predispose patients to pigmentation complications after chemical peeling and worsening the skin discoloration that the chemical peel was intended to eradicate. Patients taking blood thinners, such as warfarin, should avoid deep peels (...) Skin Resurfacing, Chemical Peels Chemical Peels: Background, Indications, Contraindications Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTgyOTEyMC1vdmVydmlldw== processing > Chemical Peels Updated: Jul 26, 2017

2014 eMedicine Surgery

56. Skin Tumors, Vascular Lesions, Face and Neck

their coagulopathy should it become life threatening (see the images below). Therapy is directed at treating the tumor with agents such as corticosteroids, vincristine, or interferon. [ , ] Deep vascular tumor with overlying skin discoloration in a 2-week-old infant with thrombocytopenia. T2-weighted MRI of the infant in the image above demonstrating depth, infiltrative characteristics, and enhancement on T2-weighted imaging in this lesion, eventually proven to be kaposiform hemangioendothelioma (KHE (...) firm lesions that infiltrate the surrounding normal tissues. These lesions most commonly occur superior to the mylohyoid muscle, in the oral cavity for example (see the image below). Macrocystic lesions are more often softer and more easily compressed. They commonly appear underneath blueish discolored skin and as translucent swellings when exposed surgically. [ ] They are usually less infiltrative into surrounding normal tissue. All patients with lymphatic malformations of the head and neck should

2014 eMedicine Surgery

57. Skin Cancer: Merkel Cell Carcinoma

with this mass. Her medical history included no previous cutaneous malignancies or sun exposure. Physical examination revealed a smooth violaceous discolored mass measuring 2 X 3 cm involving the right nasal ala. The mass deeply invaded the full thickness of the nasal skin, with evidence of right nasal obstruction as seen in the image below. The rest of her facial skin contained no additional lesions. The bilateral intraparotid and jugulodigastric nodes were normally sized. Merkel cell carcinoma affecting (...) Skin Cancer: Merkel Cell Carcinoma Skin Cancer - Merkel Cell Carcinoma: Background, History of the Procedure, Problem Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvODcwNTM4LW92ZXJ2aWV3 processing > Skin Cancer

2014 eMedicine Surgery

58. The Role of Sentinel Node Biopsy in Skin Cancer (Follow-up)

node biopsy. Long-term postoperative sequelae may include persistent blue discoloration of the skin at the injection site (for >30 d in < 10% of patients), lymphatic fistulae, lymphocele, lymphedema (generally < 2% and 0.66% in 1 large trial for sentinel node biopsy alone), and neurologic complications, including transient or persistent neurapraxia, cutaneous anesthesia, paresthesias, and neuropathy. Sentinel lymph node biopsy does not increase the risk of in-transit metastases. The risk (...) The Role of Sentinel Node Biopsy in Skin Cancer (Follow-up) The Role of Sentinel Node Biopsy in Skin Cancer Treatment & Management: Surgical Therapy, Preoperative Details, Intraoperative Details Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache

2014 eMedicine.com

59. How Long Will I Be Blue? Prolonged Skin Staining Following Sentinel Lymph Node Biopsy Using Intradermal Patent Blue Dye Full Text available with Trip Pro

How Long Will I Be Blue? Prolonged Skin Staining Following Sentinel Lymph Node Biopsy Using Intradermal Patent Blue Dye Blue dye used for sentinel lymph node biopsy (SLNB) in breast cancer patients may cause prolonged skin discoloration at the site of injection. The aim of this study was to assess the duration of such skin discoloration.236 consecutive patients who had undergone breast conserving surgery and SLNB for breast cancer were reviewed prospectively from January 2007 to December 2009 (...) .Of the 236 patients, 2 had undergone bilateral surgery, and 41 had been examined in consecutive yearly reviews. Blue discoloration remained visible at the injection site after 12, 24, and > 36 months in 36.5, 23.6, and 8.6% of the patients, respectively.The use of patent blue for identification of the sentinel lymph node in patients undergoing breast cancer surgery may result in prolonged discoloration of the skin at the injection site.

2013 Breast Care

60. A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure

A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record (...) Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal

2012 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>